JP2007512366A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512366A5 JP2007512366A5 JP2006541621A JP2006541621A JP2007512366A5 JP 2007512366 A5 JP2007512366 A5 JP 2007512366A5 JP 2006541621 A JP2006541621 A JP 2006541621A JP 2006541621 A JP2006541621 A JP 2006541621A JP 2007512366 A5 JP2007512366 A5 JP 2007512366A5
- Authority
- JP
- Japan
- Prior art keywords
- pravastatin
- compactin
- amount
- composition
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims 49
- 238000000034 method Methods 0.000 claims 46
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 claims 44
- 229960002965 pravastatin Drugs 0.000 claims 44
- 239000000203 mixture Substances 0.000 claims 34
- VGMFHMLQOYWYHN-UHFFFAOYSA-N Compactin Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)c4C(=O)C(=COc4c3)c5ccc(O)c(O)c5)C(O)C(O)C1O VGMFHMLQOYWYHN-UHFFFAOYSA-N 0.000 claims 23
- AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 claims 23
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 claims 23
- BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 claims 23
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 8
- 238000001816 cooling Methods 0.000 claims 8
- 239000003960 organic solvent Substances 0.000 claims 7
- 239000007864 aqueous solution Substances 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- 230000002194 synthesizing effect Effects 0.000 claims 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 230000033444 hydroxylation Effects 0.000 claims 3
- 238000005805 hydroxylation reaction Methods 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 150000001298 alcohols Chemical class 0.000 claims 2
- 239000003637 basic solution Substances 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 2
- 238000001179 sorption measurement Methods 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 238000005377 adsorption chromatography Methods 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 229960004844 lovastatin Drugs 0.000 claims 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims 1
- 229940032007 methylethyl ketone Drugs 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- 229960001495 pravastatin sodium Drugs 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000000741 silica gel Substances 0.000 claims 1
- 229910002027 silica gel Inorganic materials 0.000 claims 1
- 238000010189 synthetic method Methods 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52549403P | 2003-11-24 | 2003-11-24 | |
| US53231403P | 2003-12-22 | 2003-12-22 | |
| US55416504P | 2004-03-18 | 2004-03-18 | |
| PCT/US2004/039217 WO2005051372A2 (en) | 2003-11-24 | 2004-11-23 | Method of purifying pravastatin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009024212A Division JP2009161542A (ja) | 2003-11-24 | 2009-02-04 | プラバスタチンの精製方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007512366A JP2007512366A (ja) | 2007-05-17 |
| JP2007512366A5 true JP2007512366A5 (cg-RX-API-DMAC7.html) | 2008-11-20 |
Family
ID=34637188
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541621A Pending JP2007512366A (ja) | 2003-11-24 | 2004-11-23 | プラバスタチンの精製方法 |
| JP2009024212A Pending JP2009161542A (ja) | 2003-11-24 | 2009-02-04 | プラバスタチンの精製方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009024212A Pending JP2009161542A (ja) | 2003-11-24 | 2009-02-04 | プラバスタチンの精製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7425644B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2033636A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2007512366A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE412409T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2546377A1 (cg-RX-API-DMAC7.html) |
| DE (3) | DE202004020671U1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2251894T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20080686T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1641447T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1641447E (cg-RX-API-DMAC7.html) |
| TW (1) | TWI319707B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005051372A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005121062A2 (en) * | 2004-06-09 | 2005-12-22 | Ranbaxy Laboratories Limited | Process for the preparation of pravastatin |
| JP4775727B1 (ja) * | 2010-08-17 | 2011-09-21 | 貞宏 平山 | 印刷物の微小マークによる一般人が容易にできる真贋判定方法 |
| WO2014119568A1 (ja) * | 2013-01-29 | 2014-08-07 | 学校法人産業医科大学 | シスプラチン耐性がんの治療のためのHMG-CoA還元酵素阻害薬の使用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4319039A (en) * | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
| US4346277A (en) * | 1979-10-29 | 1982-08-24 | Eaton Corporation | Packaged electrical heating element |
| MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| ATE69602T1 (de) * | 1985-09-13 | 1991-12-15 | Sankyo Co | Hydroxy-ml-236b-derivate, deren herstellung und anwendung. |
| US4857547A (en) * | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
| US4857522A (en) | 1988-03-21 | 1989-08-15 | E. R. Squibb & Sons, Inc. | Derivatives of pravastatin for inhibiting cholesterol biosynthesis |
| US5180589A (en) * | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
| US5099035A (en) * | 1989-02-27 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| US5140012A (en) * | 1990-05-31 | 1992-08-18 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing pravastatin |
| US5202029A (en) | 1991-03-13 | 1993-04-13 | Caron Kabushiki Kaisha | Process for purification of hmg-coa reductase inhibitors |
| US5157025A (en) * | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
| UA45304C2 (uk) | 1992-05-20 | 2002-04-15 | Басф Аг | Похідні пептиду або їх солі, фармацевтична композиція |
| NZ250609A (en) * | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
| SI9300303A (en) * | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
| IL112639A0 (en) | 1994-03-11 | 1995-05-26 | Bristol Myers Squibb Co | A pharmaceutical composition containing pravastin |
| US5942423A (en) | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
| US5616595A (en) * | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
| WO1997006128A1 (en) | 1995-08-03 | 1997-02-20 | Gist-Brocades B.V. | Selective process for the deacylation of acylated compounds |
| US5883109A (en) | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
| AU6726398A (en) | 1997-02-20 | 1998-09-09 | Gist-Brocades B.V. | Nitrogen feed in statin fermentation |
| KR100210482B1 (ko) | 1997-04-10 | 1999-07-15 | 김종인 | 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법 |
| AU9264598A (en) | 1997-08-22 | 1999-03-16 | Gist-Brocades B.V. | Statin production by fermentation |
| SI9800046A (sl) | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
| JP2931971B1 (ja) | 1998-02-23 | 1999-08-09 | 利夫 佐藤 | プラバスタチンの製造法 |
| SI20072A (sl) * | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze |
| SI20305A (sl) | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
| SK10932001A3 (sk) | 1999-02-03 | 2002-06-04 | Institute For Drug Research Ltd. | Mikrobiálny spôsob výroby pravastatínu |
| US6682913B1 (en) | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
| HUP9902352A1 (hu) | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
| WO2001039768A1 (en) * | 1999-11-30 | 2001-06-07 | Biogal Gyogyszergyar Rt | Process for recovering statin compounds from a fermentation broth |
| WO2001081611A1 (en) * | 2000-04-27 | 2001-11-01 | Biocon India Limited | A novel process for the manufacture and purification of compactin |
| HRP20030347A2 (en) * | 2000-10-05 | 2005-04-30 | Teva Gy�gyszergy�r R�szv�nyt�rsas�g | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
| JP3463881B2 (ja) * | 2002-08-06 | 2003-11-05 | 三共株式会社 | プラバスタチン又はその薬理上許容される塩の単離・精製方法 |
| TW589178B (en) * | 2003-02-21 | 2004-06-01 | China Chemical & Pharmaceutica | A novel industrial process to obtain pravastatin sodium of high purity |
-
2004
- 2004-11-23 PL PL04811862T patent/PL1641447T3/pl unknown
- 2004-11-23 ES ES04811862T patent/ES2251894T3/es not_active Expired - Lifetime
- 2004-11-23 PT PT04811862T patent/PT1641447E/pt unknown
- 2004-11-23 DE DE202004020671U patent/DE202004020671U1/de not_active Expired - Lifetime
- 2004-11-23 EP EP08018298A patent/EP2033636A1/en not_active Withdrawn
- 2004-11-23 DE DE602004017461T patent/DE602004017461D1/de not_active Expired - Lifetime
- 2004-11-23 EP EP04811862A patent/EP1641447B1/en not_active Expired - Lifetime
- 2004-11-23 TW TW093135997A patent/TWI319707B/zh not_active IP Right Cessation
- 2004-11-23 HR HR20080686T patent/HRP20080686T3/xx unknown
- 2004-11-23 US US10/996,238 patent/US7425644B2/en not_active Expired - Fee Related
- 2004-11-23 CA CA002546377A patent/CA2546377A1/en not_active Abandoned
- 2004-11-23 JP JP2006541621A patent/JP2007512366A/ja active Pending
- 2004-11-23 DE DE04811862T patent/DE04811862T1/de active Pending
- 2004-11-23 WO PCT/US2004/039217 patent/WO2005051372A2/en not_active Ceased
- 2004-11-23 AT AT04811862T patent/ATE412409T1/de active
-
2008
- 2008-08-07 US US12/187,555 patent/US20080300305A1/en not_active Abandoned
-
2009
- 2009-02-04 JP JP2009024212A patent/JP2009161542A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0249797A (ja) | エリスロマイシンaオキシム及びその塩の製造方法 | |
| JPH11505229A (ja) | 4−アリール−ピペリジン誘導体を製造する方法 | |
| CN105294496A (zh) | 一种西酞普兰中间体的制备方法 | |
| JP2011144159A5 (cg-RX-API-DMAC7.html) | ||
| CN114805206B (zh) | 高光学纯度瑞美吉泮中间体的工业化制备方法 | |
| JP2018532718A (ja) | ホスホルアミダート化合物及びその製造方法並びに結晶 | |
| KR20100022081A (ko) | 결정성 로티고틴 염기 및 이의 제조 방법 | |
| JP2843592B2 (ja) | L−リボース誘導体 | |
| JP5664870B2 (ja) | 3環性ベンゾピラン化合物の新規な結晶形態及びその製造方法 | |
| JP2006528203A (ja) | レバルブテロールヒドロクロリド多形a | |
| KR101946808B1 (ko) | 결정성 3',5'-사이클릭 디구아닐산 | |
| EP1446397A1 (en) | Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives | |
| WO2001036359A1 (en) | Optically active fluorinated binaphthol derivative | |
| CN109705096B (zh) | 一种盐酸法舒地尔的精制方法 | |
| KR102958083B1 (ko) | 고체 형태의 tert-부틸 (S)-2-((2S,3R)-1-아미노-3-히드록시-1-옥소부탄-2-일)-1-옥소-2,5-디아자스피로[3.4]옥탄-5-카르복실레이트 및 제조 방법 | |
| JP2006506420A (ja) | 老化及びストレス調節用の薬学的に有用な新規ダウワーフェロモン化合物及びその分離精製方法 | |
| CN101805339A (zh) | 一种新方法的恩替卡韦化合物 | |
| JP2003523991A (ja) | (2s)−アミノインダン誘導体、その製法および選択的ドーパミンd3リガンドとしてのその使用 | |
| EP2367831A1 (en) | A method for the manufacture of highly pure prasugrel | |
| CN118878449B (zh) | DC-Rhoin类似物及其制备方法和应用 | |
| ES2251894T1 (es) | Procedimiento para la purificacion de pravastatina. | |
| JP2007230902A (ja) | L−グルロン酸金属塩又はd−マンヌロン酸金属塩の製造方法 | |
| KR20220066118A (ko) | B형 간염 표면 항원 억제제의 결정형 및 이의 용도 | |
| TW202423418A (zh) | 雙環類化合物的無定形、結晶固體及其製備方法 | |
| JPH0432828B2 (cg-RX-API-DMAC7.html) |